Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-25T12:37:23.920Z Has data issue: false hasContentIssue false
  • English
  • Français

Indole Excretion Patterns During Treatment with Reserpine

Published online by Cambridge University Press:  08 February 2018

A. D. Forrest
A. D. Forrest*
Affiliation:
Bangour Village Hospital, Broxburn, West Lothian
Get access Rights & Permissions [Opens in a new window]

Extract

Reserpine was first used extensively in psychiatric practice in the U.S.A. where many favourable reports on its use were published in 1954 and 1955. Subsequently a series of reports appeared in the U.K. These reports were more critical and sought to establish more precise indications for the use of the drug. It soon became apparent that the drug was of most value in schizophrenia and the organic hyperkinetic states. The value of reserpine in psychoneuroses is limited but that it is going to have a more than temporary place in the treatment of schizophrenia is suggested by the continued appearance of favourable reports. These last authors emphasize that not only is the drug an effective sedative but also that it does appear, in some places, to induce genuine remissions. The present difficulty is to predict which patients will respond in this way.

Type
Original Articles
Information
Journal of Mental Science , Volume 103 , Issue 432 , July 1957 , pp. 614 - 620
Copyright
Copyright © Royal College of Psychiatrists, 1957 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Boyland, E., Casson, J. E., and Williams, D. C., Lancet, 1956, ii, 976.Google Scholar
Brodie, B. B., Pletscher, A., and Shore, P. A., Science, 1955, 122, 968.Google Scholar
Brodie, B. B., Shore, P. A., and Pletscher, A., Science, 1956, 123, 992.CrossRefGoogle Scholar
Davies, D. L., and Shepherd, M., Lancet, 1955, ii, 117.Google Scholar
Folkson, A., and May, A. R., Brit. med. J., 1955, ii, 1121.Google Scholar
Foote, E. S., Brit. med. J., 1955, i, 1192.Google Scholar
Gaddum, J. H., J. Physiol., 1953, 119, 363.Google Scholar
Haverback, B. J., Sjoerdsma, A., and Terry, L. L., New Eng. J. Med., 1956, 255, 270.Google Scholar
Jepson, J. B., Lancet, 1956, ii, 1009.Google Scholar
Moore, J. P. N., and Martin, E. A., Brit. med. J., 1957, i, 8.Google Scholar
Rodnight, R., Biochem. J., 1956, 64, 621.Google Scholar
Shepherd, M., and Watt, D. C., J. Neurol. Neurosurg. Psychiat., 1956, 19, 232.CrossRefGoogle Scholar
Shaw, E., and Woolley, D. W., J. Biochem., 1953, 203, 979.Google Scholar
Shore, P. A., Silver, S. L., and Brodie, B. B., Science, 1955, 122, 284.CrossRefGoogle Scholar
Wing, L., J. Ment. Sci., 1956, 102, 530.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.